| 61 |
Bloodstream Infections in Febrile Neutropenic
Pediatric Cancer Patients: Microbiological and
Sepsis Biomarkers Insight |
2018 |
| 62 |
Flowcytometric CD135 Expression
and its Impact on Pediatric Acute
Lymphoblastic Leukemia at South Egypt
Cancer Institute |
2018 |
| 63 |
Flowcytometric CD135 Expression
and its Impact on Pediatric Acute
Lymphoblastic Leukemia at South Egypt
Cancer Institute |
2018 |
| 64 |
Flowcytometric CD135 Expression
and its Impact on Pediatric Acute
Lymphoblastic Leukemia at South Egypt
Cancer Institute |
2018 |
| 65 |
HCMV Among Pediatrics Acute Lymphoblastic Leukemia Patients in South Egypt Cancer Institute |
2018 |
| 66 |
Nutritional Assessment and Intervention Methods in Children at Pediatric Oncology Department |
2018 |
| 67 |
Risk-Adapted, Combined-Modality Therapy for
Unfavorable Pediatric Hodgkin Lymphom |
2018 |
| 68 |
Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom
|
2018 |
| 69 |
Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom |
2018 |
| 70 |
Can Pediatric Risk of Mortality Score (PRISM III) Be Used Effectively in Initial Evaluation and Follow-up of Critically Ill Cancer Patients Admitted to Pediatric Oncology Intensive Care Unit (POICU)? A Prospective Study, in a Tertiary Cancer Center in Egy |
2017 |
